Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
2020
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
2023 StandoutNobel
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
2021
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
2018
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
2014
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
2017
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Antibody-Based Strategies to Prevent and Treat Influenza
2015
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Specific mRNA lipid nanoparticles and acquired resistance to ticks
2023 StandoutNobel
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
2013
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
2017
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Transcriptomic profiling facilitates classification of response to influenza challenge
2014
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
2017
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
2022 StandoutNobel
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
2016
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action
2017
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies
2021 StandoutNobel
Novel universal influenza virus vaccine approaches
2016
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
2022 StandoutNobel
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
2017
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
2019
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
2020
Novel correlates of protection against pandemic H1N1 influenza A virus infection
2019
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
2019
Challenges and Promise of a Hepatitis C Virus Vaccine
2019
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
2022
Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
2017
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
2014
SARS-CoV-2 vaccines in development
2020 StandoutNature
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
2018
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model
2017
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Advances in the development of influenza virus vaccines
2015
Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury
2023 StandoutNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
2021 StandoutNobel
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
2018
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
2019
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
2017
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice
2019
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
The antigenic evolution of influenza: drift or thrift?
2013
Works of Caitlin E. Mullarkey being referenced
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
2017
Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
2013
Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
2013
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
2017
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
2012
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
2016
Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay
2015
Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+M 1 coadministration with inactivated influenza vaccine
2013
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
2016
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
2016
Fc-dependent effector functions of neutrophils induced by hemagglutinin stalk-specific antibodies
2016
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses
2019
Broadly Neutralizing Anti-Influenza Virus Antibodies: Enhancement of Neutralizing Potency in Polyclonal Mixtures and IgA Backbones
2015
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
2016